Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab or 5-FU for Pterygium Recurrence
NCT03037736Phase 4Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Mar 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules, Monoclonal Antibodies
01
Overview
A Phase 4 trial of bevacizumab, fluorouracil in pterygium, sponsored by University of California, San Francisco. Planned start Mar 2020; status: withdrawn.
02
Drugs
bevacizumabfluorouracil
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT03037736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037736.